AI assistant
Sending…
RESMED INC — Director's Dealing 2010
Nov 15, 2010
30071_dirs_2010-11-15_ddd4051b-f767-443e-abd4-8c8a0ce8efd0.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2010-11-11
Reporting Person: QUINN MICHAEL A (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2010-11-11 | ResMed Common Stock Options | $33.70 | A | 24390 | Acquired | 2017-11-11 | ResMed Common Stock (24390) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| ResMed Common Stock | 342000 | Direct |
| ResMed Common Stock | 6600 | Indirect |
Footnotes
F1: Options vest in full (i) on the first Nov. 11 following grant date or (ii) the first annual shareholder's meeting following grant date. Options have a required holding period until the earlier of (i) Nov. 11 of the third year following grant date or (ii) six months following termination of directorship.
More from RESMED INC
Regulatory Filings
2026
May 26
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Regulatory Filings
2026
Jan 29